Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02941146 · ClinicalTrials.gov registry record · NA
DualSculpting the Abdomen Using CoolSculpting
A NA study, sponsored by Zeltiq Aesthetics.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT02941146: Completed NA study, sponsored by Zeltiq Aesthetics.
NCT02941146 is a NA study that has completed, run by Zeltiq Aesthetics. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02941146, a NA study, has completed, sponsored by Zeltiq Aesthetics.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Evaluate the safety and efficacy of abdominal DualSculpting with CoolAdvantage applicators.
Primary Outcome
Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images. Reviewers will be practicing dermatologists or plastic surgeons. All reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair
Interventions
- DEVICE The ZELTIQ System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-03-29 |
| Phase | NA |
What the finished NCT02941146 record still lists
NCT02941146 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which The ZELTIQ System is the first listed.
NCT02941146 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02941146 about?
NCT02941146 is a clinical study titled "DualSculpting the Abdomen Using CoolSculpting". Evaluate the safety and efficacy of abdominal DualSculpting with CoolAdvantage applicators.
What is the current status of trial NCT02941146?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2016-10. Estimated completion is 2017-03-29.
What interventions are being tested in trial NCT02941146?
The interventions under investigation include: The ZELTIQ System (DEVICE).
Who is sponsoring clinical trial NCT02941146?
This trial is sponsored by Zeltiq Aesthetics, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02941146's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia